Elanco Director Paul Herendeen Buys 10,000 Shares in Recent Transaction
Paul Herendeen, a director at Elanco Animal Health (NYSE:ELAN), purchased 10,000 shares of the company's stock on August 7, 2026. The transaction was valued at $236,800 based on an average price per share of $23.68 and is seen as a sign of confidence in Elanco’s future performance. Elanco Animal Health operates with a market capitalization of $11.8 billion and reported trailing twelve-month revenue of $5 billion but also recorded a net loss of $199 million during the same period. The company focuses on developing, manufacturing, and commercializing animal health products for both companion animals and livestock. The stock has returned 34% over the past year, outperforming the S&P 500's nearly 20%. Herendeen now holds a total of $2.4 million worth of shares in Elanco following this purchase.
Tickers: $ELAN
Topics: Elanco Animal Health SEC Form 4 filing share purchase